Literature DB >> 6430139

Phage-typing and drug-resistance patterns as tools in mycobacterial epidemiology.

H Gruft, R Johnson, R Claflin, A Loder.   

Abstract

Phage-typing by itself was not sufficient to delineate the boundaries of a mini-epidemic of tuberculosis in upstate New York. Drug-resistance patterns were needed as well. In a small upstate community, 79% of 14 isolates tested were resistant to one or more of the antituberculosis drugs. Of 15 isolates with phage types determined, 47% were type 1(13), 27% were type 7(7, 13), and 27% were type 1(7, 12, 13). By combining phage-typing and sensitivity testing, we were able to demonstrate that 4 or possibly 5 of the 7 phage-type 1(13) strains are epidemiologically related.

Entities:  

Mesh:

Year:  1984        PMID: 6430139     DOI: 10.1164/arrd.1984.130.1.96

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  4 in total

1.  Molecular characteristics and global spread of Mycobacterium tuberculosis with a western cape F11 genotype.

Authors:  Thomas C Victor; Petra E W de Haas; Annemarie M Jordaan; Gian D van der Spuy; Madalene Richardson; D van Soolingen; Paul D van Helden; Robin Warren
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

Review 2.  Methodological and Clinical Aspects of the Molecular Epidemiology of Mycobacterium tuberculosis and Other Mycobacteria.

Authors:  Tomasz Jagielski; Alina Minias; Jakko van Ingen; Nalin Rastogi; Anna Brzostek; Anna Żaczek; Jarosław Dziadek
Journal:  Clin Microbiol Rev       Date:  2016-04       Impact factor: 26.132

3.  DNA restriction fragments length polymorphism of Mycobacterium tuberculosis isolates in Pisa, Italy.

Authors:  C Garzelli; N Lari; B Nguon; M Pistello; G Falcone
Journal:  Eur J Epidemiol       Date:  1997-10       Impact factor: 8.082

Review 4.  Current methods in the molecular typing of Mycobacterium tuberculosis and other mycobacteria.

Authors:  Tomasz Jagielski; Jakko van Ingen; Nalin Rastogi; Jarosław Dziadek; Paweł K Mazur; Jacek Bielecki
Journal:  Biomed Res Int       Date:  2014-01-05       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.